Imago BioSciences, Inc. - Common stock (NQ:IMGO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Imago BioSciences, Inc. - Common stock

< Previous 1 2 3 Next >

7 Healthcare Stocks That Will Be Big Winners in 2023 ↗

January 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

Via InvestorPlace

5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗

January 06, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

Via InvestorPlace

Looking Into Imago BioSciences's Recent Short Interest ↗

January 04, 2023

Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular...

Via Benzinga

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 03, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.

December 12, 2022

From Merck & Co., Inc.

Via Business Wire

Analyst Ratings for Imago BioSciences ↗

November 28, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About Imago BioSciences ↗

November 22, 2022

Via Benzinga

Expert Ratings for Imago BioSciences ↗

November 22, 2022

Via Benzinga

How Is The Market Feeling About Imago BioSciences? ↗

December 09, 2022

Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular...

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)

December 05, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

3 Dow Stocks to Take Seriously in 2023 ↗

November 29, 2022

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 ↗

November 28, 2022

Via Benzinga

IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO

November 22, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday ↗

November 22, 2022

Via Benzinga

TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune

November 22, 2022

Via AB Newswire

Topics Death Economy Stocks

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Nasdaq Down More Than 100 Points; Gold Falls 1% ↗

November 21, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗

November 21, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 21, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 21, 2022

During Monday's session, 50 stocks hit new 52-week highs.

Via Benzinga

OPEC Rumors, Energy Stocks Drag Wall Street ↗

November 21, 2022

The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well.

Via Talk Markets

Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher ↗

November 21, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday.

Via Benzinga

Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday ↗

November 21, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion

November 21, 2022

Imago BioSciences, Inc. (NASDAQ: IMGO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Via Spotlight Growth

As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled ↗

November 21, 2022

Markets sent mixed messages to start out Thanksgiving week.

Via The Motley Fool

Why Is Imago Biosciences (IMGO) Stock Up 105% Today? ↗

November 21, 2022

Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.

Via InvestorPlace

Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney ↗

November 21, 2022

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday.

Via Benzinga

Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout ↗

November 21, 2022

Seagen who? Merck is putting its cash to work buying a smaller biotech company.

Via Investor's Business Daily

IMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholders

November 21, 2022

From Halper Sadeh LLC

Via Business Wire

Cancer-Focused Imago BioSciences Shares Soar After Merck Deal ↗

November 21, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.